Meanwhile, in a study using a young adult mouse model of diabetes, it has been shown conclusively that inhibiting the VEGF 2 receptor (VEGFR2) improves functional outcomes and impaired BBB after stroke [35]. This evidence concerns the gene KDR and Stroke.